234 related articles for article (PubMed ID: 11129988)
21. Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium.
Arnett-Mansfield RL; DeFazio A; Mote PA; Clarke CL
J Clin Endocrinol Metab; 2004 Mar; 89(3):1429-42. PubMed ID: 15001645
[TBL] [Abstract][Full Text] [Related]
22. [Assessment of the PCNA and P53 proteins expression in the proliferative, hyperplastic and neoplastic human endometrium].
Zawiślak W; Semczuk A; Miturski R
Ginekol Pol; 2001 Dec; 72(12A):1549-54. PubMed ID: 11883313
[TBL] [Abstract][Full Text] [Related]
23. Calretinin: an immunohistochemical marker for the normal functional endometrial stroma and alterations of the immunoreactivity in dysfunctional uterine bleeding.
Al Moghrabi H; Elkeilani A; Thomas JM; Mai KT
Pathol Res Pract; 2007; 203(2):79-83. PubMed ID: 17188434
[TBL] [Abstract][Full Text] [Related]
24. Caspase cascade of Fas-mediated apoptosis in human normal endometrium and endometrial carcinoma cells.
Abe H; Shibata MA; Otsuki Y
Mol Hum Reprod; 2006 Sep; 12(9):535-41. PubMed ID: 16870953
[TBL] [Abstract][Full Text] [Related]
25. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I
Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812
[TBL] [Abstract][Full Text] [Related]
26. Metallothionein and RCAS1 expression in comparison to immunological cells activity in endometriosis, endometrial adenocarcinoma and endometrium according to menstrual cycle changes.
Wicherek L; Popiela TJ; Galazka K; Dutsch-Wicherek M; Opławski M; Basta A; Klimek M
Gynecol Oncol; 2005 Dec; 99(3):622-30. PubMed ID: 16112719
[TBL] [Abstract][Full Text] [Related]
27. Expression and prognostic significance of urokinase and plasminogen activator inhibitor type-1 in endometrial hyperplasia and cancer.
Taponeco F; Curcio C; Giuntini A; Nardini V; Fornaciari G; Artini PG; D'Ambrogio G; Genazzani AR
J Exp Clin Cancer Res; 2001 Jun; 20(2):239-46. PubMed ID: 11484981
[TBL] [Abstract][Full Text] [Related]
28. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
Ma XX; Zhang SL; Gao S; Lu JM; Dong F
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
[TBL] [Abstract][Full Text] [Related]
29. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma.
Hamid AA; Mandai M; Konishi I; Nanbu K; Tsuruta Y; Kusakari T; Kariya M; Kita M; Fujii S
Cancer; 2002 Feb; 94(4):997-1005. PubMed ID: 11920468
[TBL] [Abstract][Full Text] [Related]
30. Angiogenesis in normal, hyperplastic, and neoplastic endometrium.
Morgan KG; Wilkinson N; Buckley CH
J Pathol; 1996 Jul; 179(3):317-20. PubMed ID: 8774489
[TBL] [Abstract][Full Text] [Related]
31. BAG-1 expression in normal endometrium, endometrial hyperplasia and endometrial cancer.
Song JY; Kim JW; Lee JK; Lee NW; Yeom BW; Kim SH; Lee KW
Acta Obstet Gynecol Scand; 2008; 87(8):862-7. PubMed ID: 18704778
[TBL] [Abstract][Full Text] [Related]
32. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma.
Vaskivuo TE; Stenbäck F; Tapanainen JS
Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915
[TBL] [Abstract][Full Text] [Related]
33. Distribution of estrogen receptors in various cell types of normal, hyperplastic, and neoplastic human endometrial tissues.
Bergeron C; Ferenczy A; Shyamala G
Lab Invest; 1988 Mar; 58(3):338-45. PubMed ID: 3347010
[TBL] [Abstract][Full Text] [Related]
34. Inhibin/activin subunits beta-A (-betaA) and beta-B (-betaB) are differentially localised in normal, hyperplastic and malignant human endometrial tissue.
Mylonas I; Makovitzky J; Hoeing A; Richter DU; Vogl J; Schulze S; Jeschke U; Briese V; Friese K
Acta Histochem; 2006; 108(1):1-11. PubMed ID: 16423381
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical expression of the tumour marker CA-125 in normal, hyperplastic and malignant endometrial tissue.
Mylonas I; Makovitzky J; Richter DU; Jeschke U; Briese V; Friese K
Anticancer Res; 2003; 23(2A):1075-80. PubMed ID: 12820350
[TBL] [Abstract][Full Text] [Related]
36. Expression of cold-inducible RNA-binding protein in the normal endometrium, endometrial hyperplasia, and endometrial carcinoma.
Hamid AA; Mandai M; Fujita J; Nanbu K; Kariya M; Kusakari T; Fukuhara K; Fujii S
Int J Gynecol Pathol; 2003 Jul; 22(3):240-7. PubMed ID: 12819390
[TBL] [Abstract][Full Text] [Related]
37. Influence of the menstrual cycle on aminolevulinic acid induced protoporphyrin IX fluorescence in the endometrium: in vivo study.
Degen A; Gabrecht T; Wagnières G; Caduff R; Imthurn B; Wyss P
Lasers Surg Med; 2005 Mar; 36(3):234-7. PubMed ID: 15704091
[TBL] [Abstract][Full Text] [Related]
38. Production of activin A in hyperplasia and adenocarcinoma of the human endometrium.
Otani T; Minami S; Yamoto M; Umesaki N
Gynecol Oncol; 2001 Oct; 83(1):31-8. PubMed ID: 11585411
[TBL] [Abstract][Full Text] [Related]
39. Epithelial human chorionic gonadotropin is expressed and produced in human secretory endometrium during the normal menstrual cycle.
Zimmermann G; Ackermann W; Alexander H
Biol Reprod; 2009 May; 80(5):1053-65. PubMed ID: 19164178
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
Acs G; Xu X; Chu C; Acs P; Verma A
Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]